Silo Pharma Inc (SILO) — Cash Flow Quality Index

Latest as of June 2025: -1.25x

Silo Pharma Inc (SILO) has a Cash Flow Quality Index of -1.25x as of June 2025. Operating cash flow of $-1.29 Million is below net income of $1.03 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Silo Pharma Inc cash flow conversion to assess how effectively this company generates cash.

Cash Flow Quality Index

-1.25x
Operating CF / Net Income

Operating Cash Flow

$-1.29 Million
USD

Net Income

$1.03 Million
USD

Data as of

Jun 2025
Most recent filing

Silo Pharma Inc Cash Flow Quality Index (2013–2021)

Historical Cash Flow Quality Index for Silo Pharma Inc across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Silo Pharma Inc (SILO) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for Silo Pharma Inc (2013–2021)

Year-by-year earnings quality comparison for Silo Pharma Inc. For live market cap and the full company financial profile, see Silo Pharma Inc market capitalisation.

Year Quality Index Operating CF (USD) Net Income YoY Change
2021 -0.55x $-2.28 Million $4.16 Million ▲ +31.4%
2017 -0.80x $-284.62K $356.54K ▲ +85.5%
2013 -5.52x $-181.61K $32.91K
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.